The future looks bright for Arrowhead Pharmaceuticals Inc. (ARWR) Stock
BofA Securities raised the price target for the Arrowhead Pharmaceuticals Inc. (NASDAQ:ARWR) stock to “a Buy”. The rating was released on December 04, 2023, according to finviz. The stock was downgraded by SVB Securities, who disclosed in a research note on May 12, 2023, from Outperform to Market Perform and set the price objective to […]
Arrowhead Pharmaceuticals Inc. (ARWR) Stock: Values And Value Intersection
BofA Securities raised the price target for the Arrowhead Pharmaceuticals Inc. (NASDAQ:ARWR) stock to “a Buy”. The rating was released on December 04, 2023, according to finviz. The stock was downgraded by SVB Securities, who disclosed in a research note on May 12, 2023, from Outperform to Market Perform and set the price objective to […]
Arrowhead Pharmaceuticals Inc. (NASDAQ:ARWR) Stock is trading Lower -13.83% From 200-Day SMA
BofA Securities raised the price target for the Arrowhead Pharmaceuticals Inc. (NASDAQ:ARWR) stock to “a Buy”. The rating was released on December 04, 2023, according to finviz. The stock was downgraded by SVB Securities, who disclosed in a research note on May 12, 2023, from Outperform to Market Perform and set the price objective to […]
There is no better tap than Arrowhead Pharmaceuticals Inc. (ARWR) Stock
BofA Securities raised the price target for the Arrowhead Pharmaceuticals Inc. (NASDAQ:ARWR) stock to “a Buy”. The rating was released on December 04, 2023, according to finviz. The stock was downgraded by SVB Securities, who disclosed in a research note on May 12, 2023, from Outperform to Market Perform and set the price objective to […]
A healthy upside potential exists for Arrowhead Pharmaceuticals Inc. (ARWR) Stock
BofA Securities raised the price target for the Arrowhead Pharmaceuticals Inc. (NASDAQ:ARWR) stock to “a Buy”. The rating was released on December 04, 2023, according to finviz. The stock was downgraded by SVB Securities, who disclosed in a research note on May 12, 2023, from Outperform to Market Perform and set the price objective to […]
With upside potential, Arrowhead Pharmaceuticals Inc. (ARWR) Stock is well-positioned to grow
BofA Securities raised the price target for the Arrowhead Pharmaceuticals Inc. (NASDAQ:ARWR) stock to “a Buy”. The rating was released on December 04, 2023, according to finviz. The stock was downgraded by SVB Securities, who disclosed in a research note on May 12, 2023, from Outperform to Market Perform and set the price objective to […]
Why Arrowhead Pharmaceuticals Inc. (NASDAQ:ARWR) Stock climbed 5.13% in Last Three Months?
BofA Securities raised the price target for the Arrowhead Pharmaceuticals Inc. (NASDAQ:ARWR) stock to “a Buy”. The rating was released on December 04, 2023, according to finviz. The stock was downgraded by SVB Securities, who disclosed in a research note on May 12, 2023, from Outperform to Market Perform and set the price objective to […]
